APA-referens (7:e uppl.)

Chang, Y., Hsieh, M., Lee, H., Hee, S., Chang, C., Yen, H., . . . Chuang, L. (2025). Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity. EMBO Molecular Medicine, 17(5), 938-966. https://doi.org/10.1038/s44321-025-00216-4

Chicago-referens (17:e uppl.)

Chang, Yi-Cheng, et al. "Identification of PTGR2 Inhibitors as a New Therapeutic Strategy for Diabetes and Obesity." EMBO Molecular Medicine 17, no. 5 (2025): 938-966. https://doi.org/10.1038/s44321-025-00216-4.

MLA-referens (9:e uppl.)

Chang, Yi-Cheng, et al. "Identification of PTGR2 Inhibitors as a New Therapeutic Strategy for Diabetes and Obesity." EMBO Molecular Medicine, vol. 17, no. 5, 2025, pp. 938-966, https://doi.org/10.1038/s44321-025-00216-4.